Kabra Drugs Ltd Share Price

0.82

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 16-Oct-2019 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2019 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, be and is hereby given that the meeting of the Board of Directors of the Company will be held on Friday, November 8, 2019, inter alia, to consider the Un-Audited financial results of the company for quarter and half year ended on September 30, 2019. Please take the above intimation in your records and kindly acknowledge receipts. Thanking You, Yours Faithfully
Board Meeting - 23-Jul-2019 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2019 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company will be held on Friday, August 02, 2019 inter alia, to approve and take on record the Audited Financial Results of the Company for the quarter ended on 30th June, 2019.
Board Meeting - 17-May-2019 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, May 30, 2019 inter alia, to approve and take on record the Audited Financial Results of the Company for the quarter and year ended on 31st March 2019. Please take the above intimation in your records. Thanking You. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith audited financial result for quarter ended 31st March, 2019. Kindly take the same on your record and oblige. Thanking You. (As Per BSE Announcement Dated 30.05.2019)
Board Meeting - 24-Jan-2019 - -
KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2019 ,inter alia, to consider and approve Notice pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, be and is hereby given that the meeting of the Board of Directors of the Company will be held on Friday, February 01, 2019, inter alia, to consider the Un-Audited financial results of the company for quarter ending December 31, 2018. In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing Regulations), we wish to inform you that the Unaudited Financial Results (Standalone) of the Company for the Quarter and Half-Year ended December 31, 2018 were approved by the Board of Directors of the Company at its meeting held today. (As Per BSE Announcement Dated 01.02.2019)